GlaxoSmithKline Plc and Sanofi SA have said they will develop a vaccine to fight the fast-spreading coronavirus.

The drugmakers said they expect to start clinical trials for the vaccine in the second half of this year. If successful, the vaccine would be available in the second half of 2021.

The companies said they have also entered into a material transfer agreement, allowing them to start working together immediately.

Read the full Reuters story here.